Medicare Enrolled
Dr. Alexander Glick, M.D.
Hematology · Sarasota, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Glick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Glick? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Glick
Dr. Alexander Glick is a hematology in Sarasota, FL, with 15 years in practice. Based on federal Medicare data, Dr. Glick performed 258,285 Medicare services across 8,158 unique beneficiaries.
Between the years covered by Open Payments, Dr. Glick received a total of $16,701 from 83 pharmaceutical and/or device companies across 785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Glick is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice▲ Top 12% volume in FL$ $16,701 industry payments
Medicare Practice Summary
Medicare Utilization ↗258,285
Medicare services
Top 12% in FL for hematology
8,158
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~17,219 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 45,390 | $0 | $4 |
| Iron sucrose injection (Venofer) | 35,900 | $0 | $5 |
| Nivolumab injection (Opdivo) | 34,560 | $24 | $72 |
| Pembrolizumab injection (Keytruda) | 30,200 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 13,650 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 11,940 | $18 | $51 |
| Injection, mepolizumab, 1 mg | 11,700 | $23 | $72 |
| Epoetin alfa injection (Procrit) for anemia | 11,509 | $6 | $23 |
| Daratumumab injection (Darzalex) | 9,360 | $38 | $110 |
| Filgrastim injection (Zarxio) for white blood cells | 6,900 | $0 | $2 |
| Paclitaxel chemotherapy injection | 5,868 | $0 | $2 |
| Omalizumab injection (Xolair) for asthma/allergy | 4,410 | $30 | $95 |
| Dexamethasone injection (steroid) | 4,100 | $0 | $3 |
| Complete blood count (CBC) with differential | 3,883 | $8 | $29 |
| Immune globulin infusion (Gammagard) | 3,851 | $36 | $108 |
| Blood draw (venipuncture) | 3,708 | $8 | $9 |
| Office visit, established patient (30-39 min) | 1,980 | $94 | $339 |
| Injection, eflapegrastim-xnst, 0.1 mg | 1,980 | $25 | $116 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,860 | $1 | $28 |
| Injection, bortezomib, 0.1 mg | 1,610 | $3 | $113 |
| Drug injection, under skin or into muscle | 1,496 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 1,104 | $0 | $9 |
| Injection of additional new drug or substance into vein | 1,054 | $12 | $61 |
| Injection, fulvestrant, 25 mg | 980 | $9 | $132 |
| Injection, leucovorin calcium, per 50 mg | 833 | $3 | $12 |
| Administration of chemotherapy into vein, 1 hour or less | 740 | $96 | $378 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 616 | $1 | $6 |
| Injection, fluorouracil, 500 mg | 584 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 534 | $46 | $189 |
| Red blood count, automated test | 452 | $4 | $10 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 408 | $3 | $205 |
| Office visit, established patient, complex (40-54 min) | 386 | $135 | $474 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 328 | $16 | $59 |
| Injection, carboplatin, 50 mg | 297 | $2 | $41 |
| Injection, diphenhydramine hcl, up to 50 mg | 263 | $1 | $3 |
| Injection, potassium chloride, per 2 meq | 260 | $0 | $4 |
| Infusion into a vein for hydration, each additional hour | 259 | $10 | $42 |
| Administration of chemotherapy into vein, each additional hour | 244 | $21 | $79 |
| Injection, cisplatin, powder or solution, 10 mg | 224 | $2 | $13 |
| Office visit, established patient (20-29 min) | 221 | $61 | $239 |
| Infusion, normal saline solution , 1000 cc | 190 | $2 | $7 |
| Injection, magnesium sulfate, per 500 mg | 180 | $1 | $2 |
| Injection of drug or substance into vein | 179 | $27 | $156 |
| Injection, zoledronic acid, 1 mg | 158 | $6 | $69 |
| New patient office visit, complex (60-74 min) | 150 | $162 | $585 |
| Administration of additional new drug or substance into vein, 1 hour or less | 146 | $49 | $178 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 146 | $3 | $11 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 145 | $54 | $206 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 133 | $15 | $56 |
| Drawing of blood for a medical problem | 117 | $66 | $277 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 116 | $24 | $89 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 106 | $21 | $84 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 103 | $1 | $7 |
| Administration of additional new drug or substance into vein using push technique | 97 | $42 | $170 |
| Infusion into a vein for hydration, 31-60 minutes | 95 | $24 | $156 |
| Prothrombin time test (blood clotting) | 80 | $4 | $15 |
| Hospital follow-up visit, moderate complexity | 75 | $63 | $197 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 74 | $4 | $15 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 69 | $124 | $637 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 66 | $135 | $562 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 45 | $15 | $56 |
| Initial hospital admission, high complexity | 43 | $137 | $556 |
| Automated urinalysis | 37 | $2 | $8 |
| New patient office visit (45-59 min) | 37 | $113 | $453 |
| Administration of chemotherapy into vein using push technique | 33 | $74 | $303 |
| Advance care planning consultation, first 30 min | 23 | $65 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
19.7% high complexity
75.8% medium
4.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,701
Total received (2018-2024)
Avg $2,386/year across 7 years
Top 30% in FL for hematology
83
Companies
785
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,255 (79.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,100 (12.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,346 (8.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,309
2023$3,584
2022$2,093
2021$1,553
2020$1,278
2019$2,194
2018$1,691
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Scientific Affairs, LLC
$2,100
PFIZER INC.
$1,171
E.R. Squibb & Sons, L.L.C.
$1,081
Novartis Pharmaceuticals Corporation
$979
Janssen Biotech, Inc.
$960
Merck Sharp & Dohme Corporation
$868
Celgene Corporation
$729
Genentech USA, Inc.
$646
Merck Sharp & Dohme LLC
$606
Astellas Pharma US Inc
$565
Gilead Sciences, Inc.
$560
Amgen Inc.
$476
Incyte Corporation
$446
Seagen Inc.
$385
Exelixis Inc.
$358
Daiichi Sankyo Inc.
$340
GENZYME CORPORATION
$277
Takeda Pharmaceuticals U.S.A., Inc.
$262
ARRAY BIOPHARMA INC
$260
GlaxoSmithKline, LLC.
$253
Kite Pharma, Inc.
$230
BeiGene USA, Inc.
$199
Bayer Healthcare Pharmaceuticals Inc.
$163
ABBVIE INC.
$153
JAZZ PHARMACEUTICALS INC.
$134
ASD Specialty Healthcare, LLC
$127
Pinnacle, Inc
$121
Ethicon US, LLC
$121
Seattle Genetics, Inc.
$108
AstraZeneca Pharmaceuticals LP
$99
PharmaEssentia USA Corporation
$91
Rigel Pharmaceuticals, Inc.
$88
Lilly USA, LLC
$80
AbbVie, Inc.
$77
Myovant Sciences Inc.
$77
TerSera Therapeutics LLC
$74
Mirati Therapeutics, Inc.
$72
Stemline Therapeutics Inc.
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
Pharmacyclics LLC, An AbbVie Company
$57
Deciphera Pharmaceuticals Inc.
$55
AbbVie Inc.
$54
EISAI INC.
$52
Puma Biotechnology, Inc.
$52
Pharmacyclics LLC, an AbbVie Company
$50
Ipsen Biopharmaceuticals, Inc
$49
EMD Serono, Inc.
$49
Eisai Inc.
$48
Acrotech Biopharma LLC
$46
Helsinn Therapeutics (U.S.), Inc.
$42
SERVIER PHARMACEUTICALS LLC
$39
Genmab U.S., Inc.
$37
Bayer HealthCare Pharmaceuticals Inc.
$36
Sobi, Inc
$35
PUMA BIOTECHNOLOGY, INC.
$33
Dendreon Pharmaceuticals LLC
$32
Epizyme, Inc.,
$28
Lexicon Pharmaceuticals, Inc.
$27
Teva Pharmaceuticals USA, Inc.
$26
SpringWorks Therapeutics, Inc.
$26
Telix Pharmaceuticals
$25
Aurobindo Pharma USA, Inc.
$23
Acrotech Biopharma Inc.
$22
Kyowa Kirin, Inc.
$19
Sun Pharmaceutical Industries Inc.
$18
Heron Therapeutics, Inc.
$18
AVEO Pharmaceuticals, Inc.
$17
Regeneron Healthcare Solutions, Inc.
$16
Sumitomo Pharma America, Inc.
$16
Blueprint Medicines Corporation
$16
G1 Therapeutics, Inc.
$15
CTI BioPharma Corp.
$15
Sysmex Inostics Inc
$15
SOBI, INC
$14
Horizon Pharma plc
$14
Dova Pharmaceuticals
$14
Taiho Oncology, Inc.
$13
Agios Pharmaceuticals, Inc.
$13
Karyopharm Therapeutics Inc.
$13
SANOFI-AVENTIS U.S. LLC
$13
Alexion Pharmaceuticals, Inc.
$13
Sirtex Medical Inc
$12
Janssen Pharmaceuticals, Inc
$11
Top 3 companies account for 26.1% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CERTUS 140 MICROWAVE ABLATION SYSTEM · CINVANTI · COSELA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INVOKAMET · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LENVIMA · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · Nerlynx · Neulasta · Nplate · Nubeqa · OCREVUS · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETACRIT · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tibsovo · Trodelvy · ULTOMIRIS · VARUBI · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xolair · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (79%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $6 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
20
Per 100K population
4.5
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Glick is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), and low-engagement industry engagement, with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Glick experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Glick performed 45,390 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Glick receive payments from pharmaceutical companies?
Yes. Dr. Glick received a total of $16,701 from 83 companies across 785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Glick's costs compare to other hematologys in Sarasota?
Dr. Glick's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Glick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Sarasota
Browse hematologys in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology